De Santis Family Share Transfer at Integrated BioPharma: Governance Impact & Market Outlook
Insider share shuffle at Integrated BioPharma keeps family control intact – no price shock, but a potential prelude to future liquidity or partnership moves in the nutraceutical‑oncology niche.
4 minutes to read